Impact of trans-stent gradient on outcome after PCI: results from a HAWKEYE substudy
Authors:
Open Access
- 22 August 2022
- journal article
- research article
- Published by Springer Nature in The International Journal of Cardiovascular Imaging
- Vol. 38 (12) , 2819-2827
Abstract
To test whether quantitative flow ratio (QFR)-based trans-stent gradient (TSG) is associated with adverse clinical events at follow-up. A post-hoc analysis of the multi-center HAWKEYE study was performed. Vessels post-PCI were divided into four groups (G) as follows: G1: QFR ≥ 0.90 TSG = 0 (n = 412, 54.8%); G2: QFR ≥ 0.90, TSG > 0 (n = 216, 28.7%); G3: QFR < 0.90, TSG = 0 (n = 37, 4.9%); G4: QFR < 0.90, TSG > 0 (n = 86, 11.4%). Cox proportional hazards regression model was used to analyze the effect of baseline and prognostic variables. The final reduced model was obtained by backward stepwise variable selection. Receiver operating characteristic (ROC) was plotted and area under the curve (AUC) was calculated and reported. Overall, 449 (59.8%) vessels had a TSG = 0 whereas (40.2%) had TSG > 0. Ten (2.2%) vessel-oriented composite endpoint (VOCE) occurred in vessels with TSG = 0, compared with 43 (14%) in vessels with TSG > 0 (p < 0.01). ROC analysis showed an AUC of 0.74 (95% CI: 0.67 to 0.80; p < 0.001). TSG > 0 was an independent predictor of the VOCE (HR 2.95 [95% CI 1.77–4.91]). The combination of higher TSG and lower final QFR (G4) showed the worst long-term outcome while low TSG and high QFR showed the best outcome (G1) while either high TSG or low QFR (G2, G3) showed intermediate and comparable outcomes. Higher trans-stent gradient was an independent predictor of adverse events and identified a subgroup of patients at higher risk for poor outcomes even when vessel QFR was optimal (> 0.90).Keywords
Funding Information
- Università degli Studi di Ferrara
This publication has 32 references indexed in Scilit:
- Response by Piroth et al to Letter Regarding Article, “Prognostic Value of Fractional Flow Reserve Measured Immediately After Drug-Eluting Stent Implantation”Circulation: Cardiovascular Interventions, 2017
- Prognostic Value of Fractional Flow Reserve Measured Immediately After Drug-Eluting Stent ImplantationCirculation: Cardiovascular Interventions, 2017
- Clinical and angiographic predictors of persistently ischemic fractional flow reserve after percutaneous revascularizationAmerican Heart Journal, 2017
- Diagnostic Accuracy of Fast Computational Approaches to Derive Fractional Flow Reserve From Diagnostic Coronary AngiographyJACC: Cardiovascular Interventions, 2016
- Clinical outcomes in patients with ST-segment elevation myocardial infarction treated with everolimus-eluting stents versus bare-metal stents (EXAMINATION): 5-year results of a randomised trialThe Lancet, 2016
- Right Ventricular Strain and Dyssynchrony Assessment in Arrhythmogenic Right Ventricular CardiomyopathyCirculation: Cardiovascular Imaging, 2015
- Clinical Impact of OCT Findings During PCIJACC: Cardiovascular Imaging, 2015
- Incidence and Clinical Significance of Poststent Optical Coherence Tomography FindingsCirculation, 2015
- Stent underexpansion and residual reference segment stenosis are related to stent thrombosis after sirolimus-eluting stent implantationJACC, 2005
- Impact of final stent dimensions on long-term results following sirolimus-eluting stent implantationJACC, 2004